September 23, 2026
Breaking Barriers in Medical Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act breaking-barriers-in-medical-research-metavivor-joins-coalition-to-champion-the-clinical-trial-modernization-act

Breaking Barriers in Medical Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act

Dwi Wanna September 13, 2026
In a significant move toward dismantling the systemic barriers that hinder medical advancement, METAvivor Research and Support...
Read More Read more about Breaking Barriers in Medical Research: METAvivor Joins Coalition to Champion the Clinical Trial Modernization Act
Transforming Compassion into Action: A Comprehensive Guide to Meaningful Breast Cancer Fundraising transforming-compassion-into-action-a-comprehensive-guide-to-meaningful-breast-cancer-fundraising

Transforming Compassion into Action: A Comprehensive Guide to Meaningful Breast Cancer Fundraising

Azzam Bilal Chamdy September 13, 2026
Fundraising to support the National Breast Cancer Foundation (NBCF) and those navigating a breast cancer diagnosis is...
Read More Read more about Transforming Compassion into Action: A Comprehensive Guide to Meaningful Breast Cancer Fundraising
BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results biomarin-submits-new-drug-application-for-voxzogo-in-hypochondroplasia-following-promising-phase-iii-trial-results

BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results

Ammar Sabilarrohman September 13, 2026
San Rafael, CA – October 26, 2023 – BioMarin Pharmaceutical Inc. has announced a significant milestone in...
Read More Read more about BioMarin Submits New Drug Application for Voxzogo in Hypochondroplasia Following Promising Phase III Trial Results
Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Triple-Negative Breast Cancer beyond-the-diagnosis-how-patient-navigation-transformed-one-womans-battle-with-triple-negative-breast-cancer

Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Triple-Negative Breast Cancer

Suro Senen September 13, 2026
By Health & Wellness Editorial Staff Published: August 25, 2025 In the quiet hours of a Monday...
Read More Read more about Beyond the Diagnosis: How Patient Navigation Transformed One Woman’s Battle with Triple-Negative Breast Cancer
The Genetic Blueprint of Resilience: Largest Ever Twin Study Unlocks Secrets to Mental Health Susceptibility Legs, toes, feet and heels of newborn twins. Wrapped in a knitted white blanket. Studio macro photography of the legs of newborn twins, close-up white backgraund. Two newborns.

The Genetic Blueprint of Resilience: Largest Ever Twin Study Unlocks Secrets to Mental Health Susceptibility

Azzam Bilal Chamdy September 13, 2026
Why do two individuals, exposed to the same traumatic event or environmental stressor, walk away with vastly...
Read More Read more about The Genetic Blueprint of Resilience: Largest Ever Twin Study Unlocks Secrets to Mental Health Susceptibility

You may have missed

the-dismantling-of-u-s-global-health-a-post-mortem-on-the-restructuring-of-foreign-assistance

The Dismantling of U.S. Global Health: A Post-Mortem on the Restructuring of Foreign Assistance

Basiran September 23, 2026
metavivor-announces-strategic-transition-to-bloomerang-fundraising-platform-to-bolster-metastatic-breast-cancer-research-initiatives

METAvivor Announces Strategic Transition to Bloomerang Fundraising Platform to Bolster Metastatic Breast Cancer Research Initiatives

Ammar Sabilarrohman September 23, 2026
empower-your-center-a-10-minute-guide-to-functional-core-stability

Empower Your Center: A 10-Minute Guide to Functional Core Stability

Rifan Muazin September 23, 2026
advancing-the-frontier-of-precision-medicine-dr-jennifer-lovejoy-named-vice-president-for-translational-health-science-at-hudsonalpha

Advancing the Frontier of Precision Medicine: Dr. Jennifer Lovejoy Named Vice President for Translational Health Science at HudsonAlpha

Rifan Muazin September 23, 2026